Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America.
PLoS Genet. 2021 Nov 29;17(11):e1009935. doi: 10.1371/journal.pgen.1009935. eCollection 2021 Nov.
Genome copy number variation occurs during each mitotic and meiotic cycle and it is crucial for organisms to maintain their natural ploidy. Defects in ploidy transitions can lead to chromosome instability, which is a hallmark of cancer. Ploidy in the haploid human fungal pathogen Cryptococcus neoformans is exquisitely orchestrated and ranges from haploid to polyploid during sexual development and under various environmental and host conditions. However, the mechanisms controlling these ploidy transitions are largely unknown. During C. deneoformans (formerly C. neoformans var. neoformans, serotype D) unisexual reproduction, ploidy increases prior to the onset of meiosis, can be independent from cell-cell fusion and nuclear fusion, and likely occurs through an endoreplication pathway. To elucidate the molecular mechanisms underlying this ploidy transition, we identified twenty cell cycle-regulating genes encoding cyclins, cyclin-dependent kinases (CDK), and CDK regulators. We characterized four cyclin genes and two CDK regulator genes that were differentially expressed during unisexual reproduction and contributed to diploidization. To detect ploidy transition events, we generated a ploidy reporter, called NURAT, which can detect copy number increases via double selection for nourseothricin-resistant, uracil-prototrophic cells. Utilizing this ploidy reporter, we showed that ploidy transition from haploid to diploid can be detected during the early phases of unisexual reproduction. Interestingly, selection for the NURAT reporter revealed several instances of segmental aneuploidy of multiple chromosomes, which conferred azole resistance in some isolates. These findings provide further evidence of ploidy plasticity in fungi with significant biological and public health implications.
基因组拷贝数变异发生在有丝分裂和减数分裂周期中,对于生物体维持其自然倍性至关重要。倍性转换的缺陷会导致染色体不稳定,这是癌症的一个标志。在单倍体人类真菌病原体新型隐球菌中,倍性被精巧地调控,在有性发育和各种环境和宿主条件下,从单倍体到多倍体不等。然而,控制这些倍性转换的机制在很大程度上尚不清楚。在新型隐球菌(以前称为新型隐球菌 var. 新型隐球菌,血清型 D)的单性生殖过程中,在减数分裂开始之前,倍性增加,可以独立于细胞融合和核融合发生,并且可能通过内复制途径发生。为了阐明这种倍性转换的分子机制,我们鉴定了二十个细胞周期调节基因,这些基因编码细胞周期蛋白、细胞周期蛋白依赖性激酶(CDK)和 CDK 调节因子。我们对四个细胞周期蛋白基因和两个 CDK 调节基因进行了特征描述,这些基因在单性生殖过程中差异表达,并有助于二倍体化。为了检测倍性转换事件,我们生成了一个倍性报告基因,称为 NURAT,它可以通过对 nourseothricin 抗性、尿嘧啶原养型细胞的双重选择来检测拷贝数增加。利用这个倍性报告基因,我们表明在单性生殖的早期阶段可以检测到从单倍体到二倍体的倍性转换。有趣的是,对 NURAT 报告基因的选择揭示了多个染色体的片段性非整倍体的几个实例,这在一些分离株中赋予了唑类抗性。这些发现为真菌的倍性可塑性提供了进一步的证据,具有重要的生物学和公共卫生意义。